Agios Pharmaceuticals Inc (AGIO) verðbréfaverð og fréttir – Google Finance

Fjármál

HeimAGIO • NASDAQ

Agios Pharmaceuticals Inc

26,78 $

20. jan., 14:00:15 GMT-5 · USD · NASDAQ · Lagalegir fyrirvarar

ACADIA Pharmaceuticals Inc

26,16 $

ACAD0,65%

Alnylam Pharmaceuticals, Inc.

353,10 $

ALNY1,72%

Amgen Inc

329,46 $

AMGN0,29%

ADMA Biologics Inc

17,40 $

ADMA0,52%

Alkermes Plc

31,76 $

ALKS0,40%

Adaptive Biotechnologies Corp

17,67 $

ADPT0,86%

AbbVie Common Stock

213,51 $

ABBV0,38%

Akebia Therapeutics Inc

1,34 $

AKBA1,84%

Abbott Laboratories

120,90 $

ABT0,70%

Aclaris Therapeutics Inc

4,73 $

ACRS80,53%

HlutabréfSkráð hlutabréf í Bandaríkin

Við síðustu lokun

27,19 $

Dagbil

26,25 $ - 27,08 $

Árabil

22,24 $ - 45,99 $

Markaðsvirði

1,56 ma. USD

Meðalmagn

1,40 m.

V/H-hlutf.

-

A/V-hlutfall

-

Aðalkauphöll

NASDAQ

Viðskiptafréttir

fyrir 17 mínútum

UBS Group Cuts Meta Platforms (NASDAQ:META) Price Target to $830.00

fyrir 1 klukkustund

Dow Jones Today: DJIA Sinks as Trump Doubles Down on Greenland, EU Prepares Countermeasures

fyrir 1 klukkustund

Dow falls by more than 500 points in midday trading, as Treasurys also slide and dollar weakens

fyrir 4 klukkustundum

Stock market today: Dow, S&P 500, Nasdaq sink as Trump tariff threats and bond sell-off rattle nerves

fyrir 10 klukkustundum

Why Japan’s PM is calling an election three months into office

fyrir 18 klukkustundum

NYSE Builds Venue for 24/7 Trading of Tokenized Stocks, ETFs

Um

Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia

Stofnsett

2008

Vefsvæði

Starfsfólk

487

Leit

Hreinsa leit

Loka leit

Google forrit

Aðalvalmynd